Historical shareholding details of NT FGR Wrd SmCp LwCb EqIdx Fdr holdings in Catalyst Pharmaceuticals Inc (CPRX)

Monthly changes of NT FGR Wrd SmCp LwCb EqIdx Fdr shareholding in Catalyst Pharmaceuticals Inc over the previous months

Month Name Total no. shares held Percent Holding
Nov 30, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 51,505 0.04%
Sep 30, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 44,584 0.04%
Aug 31, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 44,584 0.04%
Jul 31, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 44,584 0.04%
Jun 30, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 44,584 0.04%
May 31, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 44,584 0.04%
Apr 30, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 39,581 0.03%
Mar 31, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 39,581 0.03%
Feb 28, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 39,581 0.03%
Jan 31, 2025 Nt Fgr Wrd Smcp Lwcb Eqidx Fdr 39,581 0.03%
Dec 31, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 34,680 0.03%
Nov 30, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 34,680 0.03%
Oct 31, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
Sep 30, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
Aug 31, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
Jul 31, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
Jun 30, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
May 31, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
Apr 30, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
Mar 31, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
Feb 29, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 32,679 0.03%
Jan 31, 2024 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 25,664 0.02%
Dec 31, 2023 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 25,664 0.02%
Nov 30, 2023 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 25,664 0.02%
Oct 31, 2023 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 25,664 0.02%
Sep 30, 2023 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 25,664 0.02%
Jun 30, 2023 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 25,664 0.02%
May 31, 2023 Nt Ucits Fgr Wrd Sm Cp Esg Lw Cb Idx Fdr 25,664 0.02%

View all ownership details of Catalyst Pharmaceuticals Inc